Photo: Seda Yalova/Shutterstock
Health regulator Anvisa granted emergency use approval to the coronavirus vaccine developed by Johnson & Johnson.
The Health Ministry had already announced a purchase deal for 38 million doses of the vaccine, which only requires a single shot to protect against coronavirus infection. The first batches are expected to arrive in the country during the second half of the year.
The vaccine is the fourth to receive approval in Brazil, after the Chinese-made CoronaVac — and immunizers developed by Pfizer and AstraZeneca, which obtained permanent approval.
Panama was once a part of Colombia. Its canal, a monumental engineering achievement of its…
The specialization trend among corporate board members It is not only a matter of perception:…
Panama will hold its presidential elections on Sunday, months after huge protests saw thousands descend…
The city of Rio de Janeiro estimates that a Madonna concert this Saturday on Copacabana…
Latin America’s trend of banning opposition candidates from elections has caught on in an ever-growing…
The São Paulo City Council on Thursday approved legislation authorizing Brazil’s largest city to sign…